Lupus Science and Medicine (Mar 2024)

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

  • Giulio Cavalli,
  • Julia Weinmann-Menke,
  • Clive Drakeford,
  • Mi Kwon,
  • Peter Gergely,
  • Tamas Shisha,
  • Pere Barba,
  • Eva Wagner-Drouet,
  • Josefina Cortés Hernández,
  • José María Álvaro-Gracia Álvaro,
  • Ozana Fischer,
  • Beata Kovacs,
  • Frédérique Chaperon,
  • David Pearson,
  • Tiina Kirsilä,
  • Chih-Yung Sean Lee

DOI
https://doi.org/10.1136/lupus-2024-el.222
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.